Category Patents/Designs/Trade Secrets

Expect Strong IP Push From Global Pharma Industry Next Year; WHO Prescribes Dose Of Reality

NEW YORK - Strong intellectual property rights will be a top priority for the pharmaceutical industry internationally in the coming year and arguments over IPRs versus medicines access are false, a top representative said at a high-level industry event this week. But views at the event differed on expectations of industry in light of the Ebola crisis, hepatitis C drug costs or other medicines access questions.

WTO, WHO, WIPO Examine IPRs And Middle-Income Countries

The current income-based grouping of countries needs to be changed or access to medicines in middle-income countries will worsen, several speakers said yesterday at a joint meeting between three international organisations on health, trade, and intellectual property. But middle-income countries should step up their engagement in organisations such as the World Health Organization, according to WHO and civil society.

European Commission Holds Consultation On Patents And Standards

The European Commission Directorate General for Enterprise and Industry is gathering stakeholder input on standardisation and intellectual property rights, in order to assess the current framework on patents and standard and look at how it should evolve. Standard-setting cuts across many organisations at the national, European and international levels. Views are being sought until January 2015.

WHO Ebola Vaccine Meeting Draws Commitment From Pharma, Donors; MSF Sees Need For Concrete Actions

A high-level meeting convened by the World Health Organization yesterday on the issue of access to and financing of Ebola vaccines resulted in a set of commitments, though not with sufficient urgency for those working on the ground. The pharmaceutical industry committed to scale up production, while donors pledged funds without disclosing how deep their pockets might be.

USPTO Director-Nominee Lee Calls For ‘Responsible Stewardship’ Of Patent System

In perhaps her first big speech since being nominated by President Obama to head the United States Patent and Trademark Office (USPTO), Michelle Lee today told an industry meeting today to use the patent system responsibly and with balance. The agency is embarking on a new global effort to streamline processes and improve quality. And for the first time in a long time, she said, USPTO has the financial resources to do it.